Oncorus

$29.45
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.65 (+2.26%) As of 4:33 PM UTC today

Why Robinhood?

You can buy or sell Oncorus and other stocks, options, and ETFs commission-free!

About ONCR

Oncorus, Inc. engages in the research and development of viral immunotherapies platform. It develops immunotherapy platform to treat cancer such as oncolytic Herpes Simplex Virus Platform and Synthetic Virus Platform. The company was founded by Mitchell H. Finer, Joseph C. Glorioso III, Kenneth P. Greenberg, Cyrus D. Mozayeni, and Paola Grandi on April 1, 2015 and is headquartered in Cambridge, MA. The listed name for ONCR is Oncorus, Inc. Common Stock.

CEO
Theodore T. Ashburn
Employees
Headquarters
Cambridge, Massachusetts
Founded
2015
Market Cap
656.54M
Price-Earnings Ratio
Dividend Yield
Average Volume
137.06K
High Today
$29.47
Low Today
$28.36
Open Price
$28.36
Volume
36.60K
52 Week High
$30.79
52 Week Low
$14.60

Collections

ONCR Earnings

-$21.73
-$14.49
-$7.24
$0.00
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Jan 29, Pre-Market

You May Also Like